We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
AUM
$5.1B
AUM Growth
+$1.47B
Cap. Flow
+$410M
Cap. Flow %
8.05%
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$102M
2
NVDA icon
NVIDIA
NVDA
+$95.9M
3
MSFT icon
Microsoft
MSFT
+$92.5M
4
GFS icon
GlobalFoundries
GFS
+$80.1M
5
MDLN
Medline Inc
MDLN
+$62.3M

Sector Composition

Rank Sector Weight
1 Industrials 29.61%
2 Miscellaneous 19.42%
3 Communication Services 10.49%
4 Technology 8.3%
5 Healthcare 7.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLRKU
251
Bluerock Acquisition Corp Unit
BLRKU
$1.03M 0.02%
100,000
CADL icon
252
Candel Therapeutics
CADL
$1B
$1.03M 0.02%
100,000
-100,000
-50% -$755K
PCAP
253
ProCap Acquisition Corp
PCAP
$329M
$1.03M 0.02%
100,000
SUJA
254
Suja Life Inc
SUJA
$223M
$1.02M 0.02%
+100,000
New +$1.34M
MBVI
255
M3-Brigade Acquisition VI Corp
MBVI
$440M
$1.01M 0.02%
100,000
BWIV.U
256
Blue Water Acquisition Corp IV Units
BWIV.U
$1M 0.02%
100,000
DGAC.U
257
Disciplined Growth Acquisition Corp Units
DGAC.U
$1M 0.02%
+100,000
New +$1M
ITHA
258
ITHAX Acquisition Corp III
ITHA
$308M
$998K 0.02%
100,000
XFLH
259
XFLH Capital Corp
XFLH
$997K 0.02%
+100,000
New +$994K
ARTC
260
Art Technology Acquisition Corp
ARTC
$994K 0.02%
100,000
MEVO
261
M Evo Global Acquisition Corp II
MEVO
$400M
$992K 0.02%
100,000
PALO
262
Paloma Acquisition Corp I
PALO
$990K 0.02%
+100,000
New +$989K
JCAP
263
Jefferson Capital
JCAP
$1.21B
$974K 0.02%
50,000
SFD
264
Smithfield Foods
SFD
$8.64B
$970K 0.02%
40,000
-35,000
-47% -$935K
MH
265
McGraw Hill
MH
$2.53B
$947K 0.02%
100,000
-150,000
-60% -$1.81M
IVA
266
Inventiva
IVA
$1.11B
$945K 0.02%
+250,000
New +$1.2M
NIQ
267
NIQ Global Intelligence PLC
NIQ
$5.66B
$935K 0.02%
100,000
-150,000
-60% -$1.45M
TRVI icon
268
Trevi Therapeutics
TRVI
$2.39B
$933K 0.02%
+50,000
New +$727K
LMRI
269
Lumexa Imaging Holdings
LMRI
$1.11B
$846K 0.02%
75,000
NTSK
270
Netskope Inc
NTSK
$6.1B
$821K 0.02%
75,000
-25,000
-25% -$255K
AKTS
271
Aktis Oncology
AKTS
$1.43B
$806K 0.02%
25,000
REA
272
Rare Earths Americas Inc
REA
$278M
$764K 0.02%
+50,000
New +$986K
CLDX icon
273
Celldex Therapeutics
CLDX
$3.07B
$744K 0.01%
+20,000
New +$646K
MPLT
274
MapLight Therapeutics
MPLT
$584M
$717K 0.01%
20,000
SENS icon
275
Senseonics Holdings Inc
SENS
$493M
$710K 0.01%
+125,000
New +$801K

Similar funds

Ghisallo Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.

On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.

  • Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
  • Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
  • Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
  • Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
  • Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
  • Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
  • Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.

Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.